Author

Xiangqiong Gu

Observed institutions: Duke University, Duke Clinical Research Institute, New York University

OpenAlex ID: A5021901404

Impact of Complete Revascularization in the ISCHEMIA Trial

2023 · Gregg W. Stone, Ziad A. Ali, et al. · Journal of the American College of Cardiology · 47

Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial

2019 · Jonathan D. Newman, Karen P. Alexander, et al. · Circulation Cardiovascular Quality and Outcomes · 30

Impact of Regional Systems of Care on Disparities in Care Among Female and Black Patients Presenting With ST‐Segment–Elevation Myocardial Infarction

2017 · Tomoya T. Hinohara, Hussein R. Al‐Khalidi, et al. · Journal of the American Heart Association · 25

Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program

2019 · Jay S Shavadia, Abhinav Sharma, et al. · Clinical Trials · 14

Predictors of Ldl-cholesterol and Systolic Blood Pressure (sbp) Goal Attainment at One Year: Interim Data From the Ischemia Trial

2018 · Jonathan D. Newman, Karen Alexander, et al. · Journal of the American College of Cardiology

Works count: 7

Citation count: 116

H-index: 4

I10-index: 4